<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-260" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>CHARGE Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Usman</surname>
            <given-names>Norina</given-names>
          </name>
          <aff>VA palo alto Stanford CA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sur</surname>
            <given-names>Moushumi</given-names>
          </name>
          <aff>Baylor College of Med, TX Children Hosp</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Norina Usman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Moushumi Sur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-260.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>CHARGE syndrome is an inherited disorder caused by a mutation in the DNA-binding protein-7 CHD7 gene. CHARGE syndrome is an acronym for coloboma, heart disease, atresia of the choanae, retarded growth and mental development, genital anomalies, and ear malformations and hearing loss. CHARGE syndrome can have high morbidity, but the morbidity can be minimized by early diagnosis and treatment. This activity reviews the pathophysiology, evaluation, and treatment of CHARGE syndrome and highlights the role of the interprofessional team in managing patients and counseling families of patients with this syndrome.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the etiology and describe the pathophysiology of CHARGE syndrome.</p></list-item><list-item><p>Outline the typical presentation and most common physical examination findings associated with CHARGE syndrome.</p></list-item><list-item><p>Summarize the important aspects of medical and surgical management of CHARGE syndrome, including occupational, physical, and speech therapy.</p></list-item><list-item><p>Review the importance of collaboration and communication amongst the interprofessional team to enhance the delivery of care for patients affected by CHARGE syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=260&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=260">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-260.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>CHARGE syndrome is a rare, autosomal dominant genetic disorder commonly diagnosed during the prenatal or neonatal period due to the&#x000a0;identification of numerous dysmorphic and congenital anomalies. The features of CHARGE syndrome were first described independently by Hall and Hittner, and hence, it was initially called Hall-Hittner syndrome. Pagon first described the cardinal anomalies such as coloboma, choanal atresia, heart defects, genital abnormalities, retarded growth, and ear malformation and coined the term CHARGE syndrome. Diagnosis is now made using criteria proposed by Blake et al.<xref ref-type="bibr" rid="article-260.r1">[1]</xref> and further modified by Verloes,<xref ref-type="bibr" rid="article-260.r2">[2]</xref>&#x000a0;who highlighted the importance of the 3C triad (coloboma, choanal atresia, abnormal semicircular canals). Other&#x000a0;criteria include orofacial cleft, distinctive facial appearance, tracheoesophageal fistula, limb abnormalities, and rarely, immune deficiencies. See <bold>Image.</bold> CHARGE Syndrome.</p>
        <p>Mutations in the&#x000a0;CHD7 (chromodomain helicase DNA binding protein)&#x000a0;gene present on 8q12&#x000a0;results in several structural and physiological abnormalities, including hearing and vision loss, heart defects, and gastrointestinal (GI) problems. Among these, GI problems have a deep influence through an individual's life, with a subsequent increase in morbidity and mortality.</p>
      </sec>
      <sec id="article-260.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Mutations in the CHD7 gene is the most common cause of CHARGE syndrome. In the rare case, it is autosomal dominant inheritance, which means it is transmitted from parent to child. Most&#x000a0;cases arise from&#x000a0;de novo mutations, which means that they are not inherited but occur sporadically. Therefore,&#x000a0;abnormalities of the CHD7 gene, which usually occur de novo,&#x000a0;can be found in over 90% of all children who meet the clinical diagnostic criteria.</p>
        <p>The&#x000a0;CHD7&#x000a0;gene controls&#x000a0;the creation of a protein that regulates developmental pathways through chromatin organization. Mutations in the&#x000a0;CHD7&#x000a0;gene lead to the making of an abnormally nonfunctional, short&#x000a0;CHD7&#x000a0;protein, which interrupts the regulation of gene expression and disordered neural crest development. If these changes occur during the embryonic period, it leads to the development of the typically pleiotropic signs and symptoms of CHARGE syndrome.<xref ref-type="bibr" rid="article-260.r3">[3]</xref></p>
      </sec>
      <sec id="article-260.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CHARGE syndrome is a congenital disorder with an incidence of approximately 1 in 10000 births. It does not have sex-linked expression, so both males and females are equally affected. Most cases are sporadic and not inherited, but mean paternal age appears to be slightly increased. In 2010, a study on 379 patients diagnosed with CHARGE syndrome was conducted, followed by CHD7 mutation testing, and the result proved that 67% of cases were due to a CHD7 mutation.<xref ref-type="bibr" rid="article-260.r4">[4]</xref>&#x000a0;There is a low recurrence rate of 1%.</p>
      </sec>
      <sec id="article-260.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Neural crest cells play an essential role in giving rise to its derivatives, including bone, pigment, smooth muscle, endocrine cells, neurons, glia as well as cartilage. Anomalies in neural crest-derived tissues can cause CHARGE syndrome. Deficiency in the passage of cervical neural crest cells into the pharyngeal pouches and arches, lack of mesoderm development, the defective interface between neural crest cells and mesoderm can subsequently lead to multiple phenotypic abnormalities. Mutations in the DNA-binding protein 7 (CHD7) gene cause CHARGE syndrome, as CHD7 plays a vital role in neural crest development.<xref ref-type="bibr" rid="article-260.r5">[5]</xref></p>
      </sec>
      <sec id="article-260.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>CHARGE syndrome is a pleiotropic disorder, including coloboma, heart defects, choanal atresia, retarded growth, genital abnormalities, ear anomalies, and deafness. A constant feature in CHARGE syndrome is semicircular canal hypoplasia ensuing in vestibular areflexia.<xref ref-type="bibr" rid="article-260.r6">[6]</xref>&#x000a0;Other associated congenital disabilities involve bilateral or unilateral coloboma of the iris, bilateral or unilateral choanal stenosis or atresia. On physical examination, other abnormalities such as cranial nerve abnormalities, including anosmia, facial palsy (bilateral or unilateral), impaired hearing, and difficulty in swallowing, have been observed.&#x000a0;Other features in CHARGE syndrome are abnormal ear shape, cryptorchidism, hypogonadism in both females and males, developmental delay, orofacial clefts, and tracheoesophageal fistula. Specific behavioral problems, such as autistic-like behavior, have been defined as well.<xref ref-type="bibr" rid="article-260.r7">[7]</xref><xref ref-type="bibr" rid="article-260.r8">[8]</xref></p>
        <p>A detailed history&#x000a0;and a consideration of prenatal, neonatal, and childhood presentations are required. The prenatal&#x000a0;performance needs to be assessed when poor fetal development, intrauterine growth restriction (IUGR), cleft lip or cleft palate, or a congenital heart defect is&#x000a0;found in utero.</p>
        <p>Neonates with CHARGE syndrome have multiple life-threatening medical conditions like small for gestational age, unable to pass&#x000a0;nasogastric&#x000a0;tube due to choanal atresia, dysmorphic features, and respiratory distress. Feeding difficulties are a significant cause of morbidity in all age groups.</p>
      </sec>
      <sec id="article-260.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of CHARGE syndrome is initially based on temporal bone imaging and clinical findings. The only gene associated with CHARGE syndrome is&#x000a0;CHD7, encrypting the chromodomain helicase DNA binding protein. This sequencing detects pathogenic variants in maximum individuals with typical CHARGE syndrome with the following criteria of having the three primary characteristics or four major and three minor characteristics. The major criteria are the 4 C's: coloboma, cranial nerve abnormalities, choanal atresia, and typical CHARGE ear. The minor criteria are heart defects, cleft lip or palate, genital abnormalities, hypotonia, kidney abnormalities, esophageal atresia, poor growth, typical CHARGE face, and typical CHARGE hand.</p>
        <p>In general,&#x000a0;CHD7&#x000a0;analysis in individuals with either fewer major components or typical CHARGE syndrome&#x000a0;detects pathogenic variants in around 65%-70% of cases.<xref ref-type="bibr" rid="article-260.r9">[9]</xref>&#x000a0;The outline of diagnosis is summarized as clinical presentation, laboratory evaluation, genetic analysis, and imaging studies:<xref ref-type="bibr" rid="article-260.r9">[9]</xref>&#x000a0; &#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Clinical diagnosis: It is a combination of major and minor diagnostic characteristics, having the three primary features or four major and three minor characteristics.</p>
          </list-item>
          <list-item>
            <p>Laboratory analysis: It includes having the blood workup done, such as complete blood count (CBC), serum electrolytes, renal function test, luteinizing hormone-releasing hormone, Human chorionic gonadotropin (hCG), blood urea nitrogen (BUN), creatinine, growth hormone levels, and immunologic studies.</p>
          </list-item>
          <list-item>
            <p>Genetic analysis: Prenatal screening for&#x000a0;CHD7&#x000a0;variants is restricted to familial cases, via amniocentesis chorionic or villus sampling at 10&#x02013;12 and 18&#x02013;20 weeks&#x02019; gestation.</p>
          </list-item>
          <list-item>
            <p>Imaging studies: Involves a skeletal survey, abdominal ultrasound, barium swallow, echocardiography, chest x-ray, cranial ultrasound in neonates, and head&#x000a0;computed tomography (CT) scan and magnetic resonance imaging (MRI).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-260.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>CHARGE syndrome patients need careful medical as well as surgical management strategies. Management is dependent on timing, features, and severity of the presentation.&#x000a0;The most common neonatal emergencies in CHARGE syndrome include cyanosis due to congenital heart defects, or bilateral posterior choanal atresia, less likely due to trachea-esophageal fistula.<xref ref-type="bibr" rid="article-260.r1">[1]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Therefore, all patients suspected of having CHARGE syndrome should have a cardiology consultation. If the infant has patent ductus arteriosus and limited pulmonary blood flow, prostaglandin should be given to maintain ductal patency.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Some cases require tracheostomy to manage chronic airway difficulties, aspiration, or gastroesophageal reflux disease. Children with CHARGE syndrome need extensive medical management of their feeding difficulties, regularly needing jejunostomy or gastrostomy feeding tubes.<xref ref-type="bibr" rid="article-260.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>In children with CHARGE syndrome, intubation may be&#x000a0;very difficult. Hence, a pediatric otolaryngologist or anesthesiologist should be present for&#x000a0;planned surgical procedures.</p>
          </list-item>
          <list-item>
            <p>In patients with facial palsy, corneal scarring can be prevented by using artificial tears. Hearing aids should be used as quickly as hearing loss is recognized with regular followup.</p>
          </list-item>
          <list-item>
            <p>Regular remolding of the earpieces is required as the ear canals can be tiny initially, and ear cartilage may be inadequate to support a hearing aid. Cochlear implantations have been efficaciously done in CHARGE syndrome patients.<xref ref-type="bibr" rid="article-260.r11">[11]</xref>&#x000a0;Children with CHARGE syndrome who experience cochlear implantation should be allowed to learn about sign language along with their communicative speech training.</p>
          </list-item>
          <list-item>
            <p>For endocrine issues, sex steroid therapy must be used for the descent of testes and penile growth in males with CHARGE syndrome. Testosterone is given for incomplete and delayed male puberty during adolescence. Females are given hormone replacement therapy if indicated at puberty. The use of sex hormone replacement can prevent osteoporosis.</p>
          </list-item>
          <list-item>
            <p>Assessment for cleft palate, together with submucous cleft palate and surgical correction at the appropriate age, must be done by an oral maxillofacial surgeon.</p>
          </list-item>
          <list-item>
            <p>Physical examination to evaluate the integrity of the cranial nerve in patients presenting with facial palsy.</p>
          </list-item>
          <list-item>
            <p>Ongoing and regular&#x000a0;consultation with a genetic counselor or geneticist&#x000a0;is recommended.<xref ref-type="bibr" rid="article-260.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-260.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>2 deletion syndrome</p>
          </list-item>
          <list-item>
            <p>Isolated coloboma</p>
          </list-item>
          <list-item>
            <p>Isolated choanal atresia</p>
          </list-item>
          <list-item>
            <p>Isolated congenital heart defects</p>
          </list-item>
          <list-item>
            <p>Cat-eye syndrome</p>
          </list-item>
          <list-item>
            <p>Joubert spectrum</p>
          </list-item>
          <list-item>
            <p>Kabuki syndrome</p>
          </list-item>
          <list-item>
            <p>Holoprosencephaly spectrum disorders</p>
          </list-item>
          <list-item>
            <p>Renal coloboma syndrome</p>
          </list-item>
          <list-item>
            <p>VATER/VACTERL association</p>
          </list-item>
          <list-item>
            <p>Kalman syndrome</p>
          </list-item>
          <list-item>
            <p>Smith-Lemli-Opitz syndrome</p>
          </list-item>
          <list-item>
            <p>DiGeorge syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-260.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients in the early years of life (infant age) are at high risk, specifically those infants who have severe congenital disabilities, resulting in poor outcomes and, thus, a high morbidity and mortality rate. Patients are most vulnerable in the first year of life and more prone to have an infection, require frequent hospitalization, and need complex surgeries, including congenital heart surgery. In late childhood through adulthood, more common causes of death include infection, aspiration, and obstructive sleep apnea. Widespread bilateral coloboma resulting in poor vision, brain malformation, microcephaly,&#x000a0;lead to poor prognosis.<xref ref-type="bibr" rid="article-260.r13">[13]</xref></p>
      </sec>
      <sec id="article-260.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Swallowing difficulty</p>
          </list-item>
          <list-item>
            <p>Aspiration</p>
          </list-item>
          <list-item>
            <p>Corneal ulceration</p>
          </list-item>
          <list-item>
            <p>Retinal detachment</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-260.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Families of patients with CHARGE syndrome need education about the disease manifestations and possible complications. Genetic counseling should be accessible for individuals at increased risk for potentially affected&#x000a0;offspring to describe options in future pregnancies, including preimplantation and prenatal genetic diagnosis. Children with CHARGE syndrome&#x000a0;can be assessed on a case by case basis. Some may require full-time support and individualized programs, and some may need little assistance. An essential step in dealing with abnormal behavior is understanding why it is occurring and helping the child learn more suitable methods of interaction. Before a child reaches the age of eighteen, care must be transitioned to adult&#x000a0;clinicians and specialists that will&#x000a0;manage the individual in later years.</p>
      </sec>
      <sec id="article-260.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team that offers a complete and unified&#x000a0;approach to deliver services can&#x000a0;accomplish the best results for a patient with CHARGE syndrome. Early identification of the syndrome and diagnostic workup to identify individual manifestations will help to prevent the associated complications. CHARGE syndrome is a heterogeneous condition, and consultation with a geneticist, pediatric cardiologist, pediatric otolaryngologist, or anesthesiologist is essential to make the shared decision that is essential for better outcomes.&#x000a0;It is necessary to use a cohesive and coordinated care pathway based on evidence in the evaluation, planning, and management of all characteristics involved in the disease. The earlier a complication is recognized and managed, the better will be the prognosis.<xref ref-type="bibr" rid="article-260.r14">[14]</xref><xref ref-type="bibr" rid="article-260.r15">[15]</xref></p>
      </sec>
      <sec id="article-260.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=260&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=260">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/charge-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=260">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/260/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=260">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-260.s15">
        <fig id="article-260.image.f1" position="float" orientation="portrait">
          <caption>
            <p>CHARGE Syndrome. The features of CHARGE syndrome include&#x000a0;coloboma of the eye, heart defects, atresia of the choanae, retardation of growth, genital underdevelopment,&#x000a0;and ear anomalies. StatPearls Publishing Illustration</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CHARGE_Syndrome_Flat-01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-260.s16">
        <title>References</title>
        <ref id="article-260.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blake</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Hefner</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>CHARGE association: an update and review for the primary pediatrician.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-73</page-range>
            <pub-id pub-id-type="pmid">9545604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanlaville</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Verloes</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>CHARGE syndrome: an update.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>389</fpage>
            <page-range>389-99</page-range>
            <pub-id pub-id-type="pmid">17299439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aramaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Udaka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kosaki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Makita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yoshihashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nanao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moriyama</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Oku</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawame</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kosaki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic spectrum of CHARGE syndrome with CHD7 mutations.</article-title>
            <source>J Pediatr</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>148</volume>
            <issue>3</issue>
            <fpage>410</fpage>
            <page-range>410-4</page-range>
            <pub-id pub-id-type="pmid">16615981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zentner</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Layman</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Scacheri</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome.</article-title>
            <source>Am J Med Genet A</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>152A</volume>
            <issue>3</issue>
            <fpage>674</fpage>
            <page-range>674-86</page-range>
            <pub-id pub-id-type="pmid">20186815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pauli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bajpai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borchers</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>CHARGEd with neural crest defects.</article-title>
            <source>Am J Med Genet C Semin Med Genet</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>478</fpage>
            <page-range>478-486</page-range>
            <pub-id pub-id-type="pmid">29082625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bellman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grace</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wyse</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Ear-nose-throat abnormalities in the CHARGE association.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-54</page-range>
            <pub-id pub-id-type="pmid">8417743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartshorne</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Grialou</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Autistic-like behavior in CHARGE syndrome.</article-title>
            <source>Am J Med Genet A</source>
            <year>2005</year>
            <month>Mar</month>
            <day>15</day>
            <volume>133A</volume>
            <issue>3</issue>
            <fpage>257</fpage>
            <page-range>257-61</page-range>
            <pub-id pub-id-type="pmid">15637726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bajpai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Rada-Iglesias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Helms</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Swigut</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wysocka</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>CHD7 cooperates with PBAF to control multipotent neural crest formation.</article-title>
            <source>Nature</source>
            <year>2010</year>
            <month>Feb</month>
            <day>18</day>
            <volume>463</volume>
            <issue>7283</issue>
            <fpage>958</fpage>
            <page-range>958-62</page-range>
            <pub-id pub-id-type="pmid">20130577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Ravenswaaij-Arts</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>New insights and advances in CHARGE syndrome: Diagnosis, etiologies, treatments, and research discoveries.</article-title>
            <source>Am J Med Genet C Semin Med Genet</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-406</page-range>
            <pub-id pub-id-type="pmid">29171162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chetty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Elmubarak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bezuidenhout</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Smit</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Urban</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>CHARGE syndrome: genetic aspects and dental challenges, a review and case presentation.</article-title>
            <source>Head Face Med</source>
            <year>2020</year>
            <month>May</month>
            <day>08</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">32384900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sethukumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rajput</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nash</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of cochlear implantation in CHARGE syndrome.</article-title>
            <source>Cochlear Implants Int</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>266</fpage>
            <page-range>266-280</page-range>
            <pub-id pub-id-type="pmid">31282293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blake</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Russell-Eggitt</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Ratcliffe</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wyse</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Who's in CHARGE? Multidisciplinary management of patients with CHARGE association.</article-title>
            <source>Arch Dis Child</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-23</page-range>
            <pub-id pub-id-type="pmid">2317068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raqbi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Bihan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morisseau-Durand</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Dureau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lyonnet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abadie</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Early prognostic factors for intellectual outcome in CHARGE syndrome.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>483</fpage>
            <page-range>483-8</page-range>
            <pub-id pub-id-type="pmid">12828403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santos-Silva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Castro-Correia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lemos</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fontoura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neonatal presentation of growth hormone deficiency in CHARGE syndrome: the benefit of early treatment on long-term growth.</article-title>
            <source>Arch Endocrinol Metab</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>487</fpage>
            <page-range>487-491</page-range>
            <pub-id pub-id-type="pmid">32267359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-260.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dijk</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Bocca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van Ravenswaaij-Arts</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach.</article-title>
            <source>J Multidiscip Healthc</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>607</fpage>
            <page-range>607-620</page-range>
            <pub-id pub-id-type="pmid">31534343</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
